Examination Report |
1 | Correspondence | 25 Dec 2010 |
10 | Journal Copy | 10 Mar 2018 |
11 | Certificate | 14 May 2018 |
12 | TM-R(RENEWAL OF TRADE MARK) | 09 Jan 2020 |
13 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 20 Nov 2020 |
2 | Additional Representation Sheet | 29 Dec 2010 |
3 | TM-1 | 29 Dec 2010 |
4 | MIS-E | 17 Oct 2012 |
5 | Reply to Exam Report (MIS-R) | 03 May 2013 |
6 | TM-16 | 07 Jan 2015 |
7 | Authorization Document (POA) | 07 Jan 2015 |
8 | TM-16 | 21 May 2015 |
9 | Hearing Notice | 21 Sep 2017 |
1 | Hearing Notice (Show Cause) | 5034035 | 14 Aug 2017 | |
2 | Hearing Notice (Adjourned) | 5355493 | 08 Nov 2017 | |
3 | Tribunal ABA Notice for : 2076825 | 5563951 | 14 Dec 2017 | |
4 | RENEWAL INTIMATION LETTER | 9689257 | 02 Feb 2020 |
The application for Aldorace was made on 29 December 2010.
The trademark applicant for Aldorace is SUN PHARMACEUTICAL INDUSTRIES LIMITED SPIL.
Aldorace is applied in class(es) 5.
Application for Aldorace is on Registered stage.
Application Id allotted to Aldorace is 2076825.
Aldorace filed with the Intellectual property office as a WORD.